pembrolizumab
merck
['lcsm,(-blcsm)', 'key,note,091', 'pearls', 'keynote,91', 'pembro', 'nsclc', 'sclc', 'thanks', ' osel']
special thanks to dr kersti oselin, of north estonia medical centre, who shared key findings from a subgroup analysis of the phase 3 pearls/keynote-091 of pembrolizumab vs placebo in early-stage nsclc after resection &amp; adjuvant therapy. #asco23 #lcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.